SEARCH

SEARCH BY CITATION

References

  • 1
    Fields S & Johnston M (2005) Cell biology. Whither model organism research? Science 307, 18851886.
  • 2
    Botstein D & Fink GR (1988) Yeast: an experimental organism for modern biology. Science 240, 14391443.
  • 3
    Khurana V & Lindquist S (2010) Modelling neurodegeneration in Saccharomyces cerevisiae: why cook with baker’s yeast? Nat Rev Neurosci 11, 436449.
  • 4
    Smith MG & Snyder M (2006) Yeast as a model for human disease. Curr Protoc Hum Genet Chapter 15, Unit 15 6.
  • 5
    Hartwell LH (2002) Nobel Lecture. Yeast and cancer. Biosci Rep 22, 373394.
  • 6
    Carmona-Gutierrez D, Ruckenstuhl C, Bauer MA, Eisenberg T, Buttner S & Madeo F (2010) Cell death in yeast: growing applications of a dying buddy. Cell Death Differ 17, 733734.
  • 7
    Goffeau A, Barrell BG, Bussey H, Davis RW, Dujon B, Feldmann H, Galibert F, Hoheisel JD, Jacq C, Johnston M et al. (1996) Life with 6000 genes. Science, 274, 546, 563567.
  • 8
    Cho RJ, Campbell MJ, Winzeler EA, Steinmetz L, Conway A, Wodicka L, Wolfsberg TG, Gabrielian AE, Landsman D, Lockhart DJ et al. (1998) A genome-wide transcriptional analysis of the mitotic cell cycle. Mol Cell 2, 6573.
  • 9
    Zhu H, Bilgin M, Bangham R, Hall D, Casamayor A, Bertone P, Lan N, Jansen R, Bidlingmaier S, Houfek T et al. (2001) Global analysis of protein activities using proteome chips. Science 293, 21012105.
  • 10
    Giaever G, Chu AM, Ni L, Connelly C, Riles L, Veronneau S, Dow S, Lucau-Danila A, Anderson K, Andre B et al. (2002) Functional profiling of the Saccharomyces cerevisiae genome. Nature 418, 387391.
  • 11
    Uetz P, Giot L, Cagney G, Mansfield TA, Judson RS, Knight JR, Lockshon D, Narayan V, Srinivasan M, Pochart P et al. (2000) A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature 403, 623627.
  • 12
    Ito T, Chiba T, Ozawa R, Yoshida M, Hattori M & Sakaki Y (2001) A comprehensive two-hybrid analysis to explore the yeast protein interactome. Proc Natl Acad Sci USA 98, 45694574.
  • 13
    Tong AH, Evangelista M, Parsons AB, Xu H, Bader GD, Page N, Robinson M, Raghibizadeh S, Hogue CW, Bussey H et al. (2001) Systematic genetic analysis with ordered arrays of yeast deletion mutants. Science 294, 23642368.
  • 14
    Jones GM, Stalker J, Humphray S, West A, Cox T, Rogers J, Dunham I & Prelich G (2008) A systematic library for comprehensive overexpression screens in Saccharomyces cerevisiae. Nat Methods 5, 239241.
  • 15
    Barberis A, Gunde T, Berset C, Audetat S & Luthi U (2005) Yeast as a screening tool. Drug Discov Today Tech 2, 5.
  • 16
    Loewith R, Jacinto E, Wullschleger S, Lorberg A, Crespo JL, Bonenfant D, Oppliger W, Jenoe P & Hall MN (2002) Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol Cell 10, 457468.
  • 17
    Coutinho I, Pereira G, Leao M, Goncalves J, Corte-Real M & Saraiva L (2009) Differential regulation of p53 function by protein kinase C isoforms revealed by a yeast cell system. FEBS Lett 583, 35823588.
  • 18
    Saraiva L, Silva RD, Pereira G, Goncalves J & Corte-Real M (2006) Specific modulation of apoptosis and Bcl-xL phosphorylation in yeast by distinct mammalian protein kinase C isoforms. J Cell Sci 119, 31713181.
  • 19
    Bulat N & Widmann C (2009) Caspase substrates and neurodegenerative diseases. Brain Res Bull 80, 251267.
  • 20
    Ghavami S, Hashemi M, Ande SR, Yeganeh B, Xiao W, Eshraghi M, Bus CJ, Kadkhoda K, Wiechec E, Halayko AJ et al. (2009) Apoptosis and cancer: mutations within caspase genes. J Med Genet 46, 497510.
  • 21
    Enoksson M & Salvesen GS (2010) Metacaspases are not caspases – always doubt. Cell Death Differ 17, 1221.
  • 22
    Madeo F, Herker E, Maldener C, Wissing S, Lachelt S, Herlan M, Fehr M, Lauber K, Sigrist SJ, Wesselborg S et al. (2002) A caspase-related protease regulates apoptosis in yeast. Mol Cell 9, 911917.
  • 23
    Vercammen D, van de Cotte B, De Jaeger G, Eeckhout D, Casteels P, Vandepoele K, Vandenberghe I, Van Beeumen J, Inze D & Van Breusegem F (2004) Type II metacaspases Atmc4 and Atmc9 of Arabidopsis thaliana cleave substrates after arginine and lysine. Cell Death Differ 279, 4532945336.
  • 24
    Puryer MA & Hawkins CJ (2006) Human, insect and nematode caspases kill Saccharomyces cerevisiae independently of YCA1 and Aif1p. Apoptosis 11, 509517.
  • 25
    Lisa-Santamaria P, Neiman AM, Cuesta-Marban A, Mollinedo F, Revuelta JL & Jimenez A (2009) Human initiator caspases trigger apoptotic and autophagic phenotypes in Saccharomyces cerevisiae. Biochim Biophys Acta 1793, 561571.
  • 26
    Kamada S, Kusano H, Fujita H, Ohtsu M, Koya RC, Kuzumaki N & Tsujimoto Y (1998) A cloning method for caspase substrates that uses the yeast two-hybrid system: cloning of the antiapoptotic gene gelsolin. Proc Natl Acad Sci USA 95, 85328537.
  • 27
    Araya R, Takahashi R & Nomura Y (2002) Yeast two-hybrid screening using constitutive-active caspase-7 as bait in the identification of PA28gamma as an effector caspase substrate. Cell Death Differ 9, 322328.
  • 28
    Hawkins CJ, Wang SL & Hay BA (1999) A cloning method to identify caspases and their regulators in yeast: identification of Drosophila IAP1 as an inhibitor of the Drosophila caspase DCP-1. Proc Natl Acad Sci USA 96, 28852890.
  • 29
    Hayashi H, Cuddy M, Shu VC, Yip KW, Madiraju C, Diaz P, Matsuyama T, Kaibara M, Taniyama K, Vasile S et al. (2009) Versatile assays for high throughput screening for activators or inhibitors of intracellular proteases and their cellular regulators. PLoS ONE 4, e7655.
  • 30
    Kang JJ, Schaber MD, Srinivasula SM, Alnemri ES, Litwack G, Hall DJ & Bjornsti MA (1999) Cascades of mammalian caspase activation in the yeast Saccharomyces cerevisiae. J Biol Chem 274, 31893198.
  • 31
    Hawkins CJ, Silke J, Verhagen AM, Foster R, Ekert PG & Ashley DM (2001) Analysis of candidate antagonists of IAP-mediated caspase inhibition using yeast reconstituted with the mammalian Apaf-1-activated apoptosis mechanism. Apoptosis 6, 331338.
  • 32
    Ryser S, Vial E, Magnenat E, Schlegel W & Maundrell K (1999) Reconstitution of caspase-mediated cell-death signalling in Schizosaccharomyces pombe. Curr Genet 36, 2128.
  • 33
    Wright ME, Han DK, Carter L, Fields S, Schwartz SM & Hockenbery DM (1999) Caspase-3 inhibits growth in Saccharomyces cerevisiae without causing cell death. FEBS Lett 446, 914.
  • 34
    Wright ME, Han DK & Hockenbery DM (2000) Caspase-3 and inhibitor of apoptosis protein(s) interactions in Saccharomyces cerevisiae and mammalian cells. FEBS Lett 481, 1318.
  • 35
    Gloria PM, Coutinho I, Goncalves LM, Baptista C, Soares J, Newton AS, Moreira R, Saraiva L & Santos MM (2011) Aspartic vinyl sulfones: inhibitors of a caspase-3-dependent pathway. Eur J Med Chem 46, 21412146.
  • 36
    Silke J, Ekert PG, Day CL, Hawkins CJ, Baca M, Chew J, Pakusch M, Verhagen AM & Vaux DL (2001) Direct inhibition of caspase 3 is dispensable for the anti-apoptotic activity of XIAP. EMBO J 20, 31143123.
  • 37
    Chipuk JE, Moldoveanu T, Llambi F, Parsons MJ & Green DR (2010) The BCL-2 family reunion. Mol Cell 37, 299310.
  • 38
    Sato T, Hanada M, Bodrug S, Irie S, Iwama N, Boise LH, Thompson CB, Golemis E, Fong L & Wang HG (1994) Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system. Proc Natl Acad Sci USA 91, 92389242.
  • 39
    Manon S, Chaudhuri B & Guerin M (1997) Release of cytochrome c and decrease of cytochrome c oxidase in Bax-expressing yeast cells, and prevention of these effects by coexpression of Bcl-xL. FEBS Lett 415, 2932.
  • 40
    Silva RD, Manon S, Goncalves J, Saraiva L & Corte-Real M (2011) The importance of humanized yeast to better understand the role of bcl-2 family in apoptosis: finding of novel therapeutic opportunities. Curr Pharm Des 17, 246255.
  • 41
    Marzo I, Brenner C, Zamzami N, Jurgensmeier JM, Susin SA, Vieira HL, Prevost MC, Xie Z, Matsuyama S, Reed JC et al. (1998) Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 281, 20272031.
  • 42
    Sanjuan Szklarz LK, Kozjak-Pavlovic V, Vogtle FN, Chacinska A, Milenkovic D, Vogel S, Durr M, Westermann B, Guiard B, Martinou JC et al. (2007) Preprotein transport machineries of yeast mitochondrial outer membrane are not required for Bax-induced release of intermembrane space proteins. J Mol Biol 368, 4454.
  • 43
    Matsuyama S, Xu Q, Velours J & Reed JC (1998) The Mitochondrial F0F1-ATPase proton pump is required for function of the proapoptotic protein Bax in yeast and mammalian cells. Mol Cell 1, 327336.
  • 44
    Gross A, Pilcher K, Blachly-Dyson E, Basso E, Jockel J, Bassik MC, Korsmeyer SJ & Forte M (2000) Biochemical and genetic analysis of the mitochondrial response of yeast to BAX and BCL-X(L). Mol Cell Biol 20, 31253136.
  • 45
    Ligr M, Madeo F, Frohlich E, Hilt W, Frohlich KU & Wolf DH (1998) Mammalian Bax triggers apoptotic changes in yeast. FEBS Lett 438, 6165.
  • 46
    Pavlov EV, Priault M, Pietkiewicz D, Cheng EH, Antonsson B, Manon S, Korsmeyer SJ, Mannella CA & Kinnally KW (2001) A novel, high conductance channel of mitochondria linked to apoptosis in mammalian cells and Bax expression in yeast. J Cell Biol 155, 725731.
  • 47
    Camougrand N, Grelaud-Coq A, Marza E, Priault M, Bessoule JJ & Manon S (2003) The product of the UTH1 gene, required for Bax-induced cell death in yeast, is involved in the response to rapamycin. Mol Microbiol 47, 495506.
  • 48
    Kissova I, Plamondon L-T, Brisson L, Priault M, Renouf V, Schaeffer J, Camougrand N & Manon S (2006) Evaluation of the roles of apoptosis, autophagy, and mitophagy in the loss of plating efficiency induced by Bax expression in yeast. J Biol Chem 281, 3618736197.
  • 49
    Yee KS, Wilkinson S, James J, Ryan KM & Vousden KH (2009) PUMA- and Bax-induced autophagy contributes to apoptosis. Cell Death Differ 16, 11351145.
  • 50
    Hanada M, Aime-Sempe C, Sato T & Reed JC (1995) Structure–function analysis of Bcl-2 protein. Identification of conserved domains important for homodimerization with Bcl-2 and heterodimerization with Bax. J Biol Chem 270, 1196211969.
  • 51
    Arokium H, Ouerfelli H, Velours G, Camougrand N, Vallette FM & Manon S (2007) Substitutions of potentially phosphorylatable serine residues of Bax reveal how they may regulate its interaction with mitochondria. J Biol Chem 282, 3510435112.
  • 52
    Priault M, Camougrand N, Chaudhuri B & Manon S (1999) Role of the C-terminal domain of Bax and Bcl-XL in their localization and function in yeast cells. FEBS Lett 443, 225228.
  • 53
    Minn AJ, Kettlun CS, Liang H, Kelekar A, Vander Heiden MG, Chang BS, Fesik SW, Fill M & Thompson CB (1999) Bcl-xL regulates apoptosis by heterodimerization-dependent and -independent mechanisms. EMBO J 18, 632643.
  • 54
    Tao W, Kurschner C & Morgan JI (1998) Bcl-xS and Bad potentiate the death suppressing activities of Bcl-xL, Bcl-2, and A1 in yeast. J Biol Chem 273, 2370423708.
  • 55
    Zha H & Reed JC (1997) Heterodimerization-independent functions of cell death regulatory proteins Bax and Bcl-2 in yeast and mammalian cells. J Biol Chem 272, 3148231488.
  • 56
    Xu Q & Reed JC (1998) Bax inhibitor-1, a mammalian apoptosis suppressor identified by functional screening in yeast. Mol Cell 1, 337346.
  • 57
    Zhang H, Xu Q, Krajewski S, Krajewska M, Xie Z, Fuess S, Kitada S, Pawlowski K, Godzik A & Reed JC (2000) BAR: an apoptosis regulator at the intersection of caspases and Bcl-2 family proteins. Proc Natl Acad Sci USA 97, 25972602.
  • 58
    Torgler CN, de Tiani M, Raven T, Aubry JP, Brown R & Meldrum E (1997) Expression of bak in S. pombe results in a lethality mediated through interaction with the calnexin homologue Cnx1. Cell Death Differ 4, 263271.
  • 59
    Dutta S, Gulla S, Chen TS, Fire E, Grant RA & Keating AE (2010) Determinants of BH3 binding specificity for Mcl-1 versus BcI-x(L). J Mol Biol 398, 747762.
  • 60
    Gutcher I, Webb PR & Anderson NG (2003) The isoform-specific regulation of apoptosis by protein kinase C. Cell Mol Life Sci 60, 10611070.
  • 61
    Reyland ME (2009) Protein kinase C isoforms: multi-functional regulators of cell life and death. Front Biosci 14, 23862399.
  • 62
    Goode NT, Hajibagheri MA, Warren G & Parker PJ (1994) Expression of mammalian protein kinase C in Schizosaccharomyces pombe: isotype-specific induction of growth arrest, vesicle formation, and endocytosis. Mol Biol Cell 5, 907920.
  • 63
    Perez P & Calonge TM (2002) Yeast protein kinase C. J Biochem 132, 513517.
  • 64
    Riedel H, Hansen H, Parissenti AM, Su L, Shieh HL & Zhu J (1993) Phorbol ester activation of functional rat protein kinase C beta-1 causes phenotype in yeast. J Cell Biochem 52, 320329.
  • 65
    Riedel H, Su L & Hansen H (1993) Yeast phenotype classifies mammalian protein kinase C cDNA mutants. Mol Cell Biol 13, 47284735.
  • 66
    Su L, Parissenti AM & Riedel H (1993) Functional carboxyl terminal deletion map of protein kinase C alpha. Receptors Channels 1, 19.
  • 67
    Parissenti AM, Su L & Riedel H (1993) Reconstitution of protein kinase C alpha function by the protein kinase C beta-I carboxy terminus. Mol Cell Endocrinol 98, 916.
  • 68
    Zhu J, Hansen H, Su L, Shieh HL & Riedel H (1994) Ligand regulation of bovine protein kinase C alpha response via either cysteine-rich repeat of conserved region C1. J Biochem 115, 10001009.
  • 69
    Shieh HL, Hansen H, Zhu J & Riedel H (1995) Differential protein kinase C ligand regulation detected in vivo by a phenotypic yeast assay. Mol Carcinog 12, 166176.
  • 70
    Guo B, Reed K & Parissenti AM (2006) Scanning mutagenesis studies reveal multiple distinct regions within the human protein kinase C alpha regulatory domain important for phorbol ester-dependent activation of the enzyme. J Mol Biol 357, 820832.
  • 71
    Rotenberg SA, Zhu J, Hansen H, Li XD, Sun XG, Michels CA & Riedel H (1998) Deletion analysis of protein kinase Calpha reveals a novel regulatory segment. J Biochem 124, 756763.
  • 72
    Kirwan AF, Bibby AC, Mvilongo T, Riedel H, Burke T, Millis SZ & Parissenti AM (2003) Inhibition of protein kinase C catalytic activity by additional regions within the human protein kinase Calpha-regulatory domain lying outside of the pseudosubstrate sequence. Biochem J 373, 571581.
  • 73
    Saraiva L, Fresco P, Pinto E & Goncalves J (2004) Characterization of phorbol esters activity on individual mammalian protein kinase C isoforms, using the yeast phenotypic assay. Eur J Pharmacol 491, 101110.
  • 74
    Saraiva L, Fresco P, Pinto E & Goncalves J (2003) Isoform-selectivity of PKC inhibitors acting at the regulatory and catalytic domain of mammalian PKC-alpha, -betaI, -delta, -eta and -zeta. J Enzyme Inhib Med Chem 18, 475483.
  • 75
    Keenan C, Goode N & Pears C (1997) Isoform specificity of activators and inhibitors of protein kinase C gamma and delta. FEBS Lett 415, 101108.
  • 76
    Saraiva L, Fresco P, Pinto E, Sousa E, Pinto M & Goncalves J (2002) Synthesis and in vivo modulatory activity of protein kinase C of xanthone derivatives. Bioorg Med Chem 10, 32193227.
  • 77
    Saraiva L, Fresco P, Pinto E, Portugal H & Goncalves J (2001) Differential activation by daphnetoxin and mezerein of PKC-isotypes alpha, beta I, delta and zeta. Planta Med 67, 787790.
  • 78
    Saraiva L, Fresco P, Pinto E, Sousa E, Pinto M & Goncalves J (2003) Inhibition of alpha, betaI, delta, eta, and zeta protein kinase C isoforms by xanthonolignoids. J Enzyme Inhib Med Chem 18, 357370.
  • 79
    Coutinho I, Pereira G, Simoes MF, Corte-Real M, Goncalves J & Saraiva L (2009) Selective activation of protein kinase C-delta and -epsilon by 6,11,12,14-tetrahydroxy-abieta-5,8,11,13-tetraene-7-one (coleon U). Biochem Pharmacol 78, 449459.
  • 80
    Maghzal N, Vogt E, Reintsch W, Fraser JS & Fagotto F (2010) The tumor-associated EpCAM regulates morphogenetic movements through intracellular signaling. J Cell Biol 191, 645659.
  • 81
    Wang QMJ, Lu GW, Schlapkohl WA, Goerke A, Larsson C, Mischak H, Blumberg PM & Mushinski JF (2004) The V5 domain of protein kinase C plays a critical role in determining the isoform-specific localization, translocation, and biological function of protein kinase C-delta and -epsilon. Mol Cancer Res 2, 129140.
  • 82
    Yoshida K (2008) Nuclear trafficking of pro-apoptotic kinases in response to DNA damage. Trends Mol Med 14, 305313.
  • 83
    DeVries-Seimon TA, Ohm AM, Humphries MJ & Reyland ME (2007) Induction of apoptosis is driven by nuclear retention of protein kinase C delta. J Biol Chem 282, 2230722314.
  • 84
    Silva RD, Manon S, Goncalves J, Saraiva L & Corte-Real M (2011) Modulation of Bax mitochondrial insertion and induced cell death in yeast by mammalian protein kinase Calpha. Exp Cell Res 317, 781790.
  • 85
    Coutinho I, Pereira C, Pereira G, Goncalves J, Corte-Real M & Saraiva L (2011) Distinct regulation of p53-mediated apoptosis by protein kinase Calpha, delta, epsilon and zeta: evidence in yeast for transcription-dependent and -independent p53 apoptotic mechanisms. Exp Cell Res 317, 11471158.
  • 86
    Du L, Lyle CS & Chambers TC (2005) Characterization of vinblastine-induced Bcl-xL and Bcl-2 phosphorylation: evidence for a novel protein kinase and a coordinated phosphorylation/dephosphorylation cycle associated with apoptosis induction. Oncogene 24, 107117.
  • 87
    Basu A & Sivaprasad U (2007) Protein kinase Cepsilon makes the life and death decision. Cell Signal 19, 16331642.
  • 88
    Nowak G (2002) Protein kinase C-alpha and ERK1/2 mediate mitochondrial dysfunction, decreases in active Na+ transport, and cisplatin-induced apoptosis in renal cells. J Biol Chem 277, 4337743388.
  • 89
    Niwa K, Inanami O, Yamamori T, Ohta T, Hamasu T, Karino T & Kuwabara M (2002) Roles of protein kinase C delta in the accumulation of P53 and the induction of apoptosis in H2O2-treated bovine endothelial cells. Free Radic Res 36, 11471153.
  • 90
    Pospisilova S, Brazda V, Kucharikova K, Luciani MG, Hupp TR, Skladal P, Palecek E & Vojtesek B (2004) Activation of the DNA-binding ability of latent p53 protein by protein kinase C is abolished by protein kinase CK2. Biochem J 378, 939947.
  • 91
    Lavin MF & Gueven N (2006) The complexity of p53 stabilization and activation. Cell Death Differ 13, 941950.
  • 92
    Yoshida K, Liu H & Miki Y (2006) Protein kinase C delta regulates Ser46 phosphorylation of p53 tumor suppressor in the apoptotic response to DNA damage. J Biol Chem 281, 57345740.
  • 93
    Sivaprasad U, Shankar E & Basu A (2007) Downregulation of Bid is associated with PKCepsilon-mediated TRAIL resistance. Cell Death Differ 14, 851860.
  • 94
    Gubina E, Rinaudo MS, Szallasi Z, Blumberg PM & Mufson RA (1998) Overexpression of protein kinase C isoform epsilon but not delta in human interleukin-3-dependent cells suppresses apoptosis and induces bcl-2 expression. Blood, 91, 823829.
  • 95
    Zhang Y, Venugopal SK, He S, Liu P, Wu J & Zern MA (2007) Ethanol induces apoptosis in hepatocytes by a pathway involving novel protein kinase C isoforms. Cell Signal 19, 23392350.
  • 96
    Cheok CF, Verma CS, Baselga J & Lane DP (2011) Translating p53 into the clinic. Nat Rev Clin Oncol 8, 2537.
  • 97
    Smardova J, Smarda J & Koptikova J (2005) Functional analysis of p53 tumor suppressor in yeast. Differentiation 73, 261277.
  • 98
    Yousef AF, Xu GW, Mendez M, Brandl CJ & Mymryk JS (2008) Coactivator requirements for p53-dependent transcription in the yeast Saccharomyces cerevisiae. Int J Cancer 122, 942946.
  • 99
    Fields S & Jang SK (1990) Presence of a potent transcription activating sequence in the p53 protein. Science, 249, 10461049.
  • 100
    Scharer E & Iggo R (1992) Mammalian p53 can function as a transcription factor in yeast. Nucleic Acids Res 20, 15391545.
  • 101
    Thiagalingam S, Kinzler KW & Vogelstein B (1995) PAK1, a gene that can regulate p53 activity in yeast. Proc Natl Acad Sci USA 92, 60626066.
  • 102
    Pearson GD & Merrill GF (1998) Deletion of the Saccharomyces cerevisiae TRR1 gene encoding thioredoxin reductase inhibits p53-dependent reporter gene expression. J Biol Chem 273, 54315434.
  • 103
    Hu JD, Ma XR, Lindner DJ, Karra S, Hofmann ER, Reddy SPM & Kalvakolanu DV (2001) Modulation of p53 dependent gene expression and cell death through thioredoxin-thioredoxin reductase by the interferon-retinoid combination. Oncogene 20, 42354248.
  • 104
    Ishioka C, Frebourg T, Yan YX, Vidal M, Friend SH, Schmidt S & Iggo R (1993) Screening patients for heterozygous p53 mutations using a functional assay in yeast. Nat Genet 5, 124129.
  • 105
    Fronza G, Inga A, Monti P, Scott G, Campomenosi P, Menichini P, Ottaggio L, Viaggi S, Burns PA, Gold B et al. (2000) The yeast p53 functional assay: a new tool for molecular epidemiology. Hopes and facts. Mutat Res 462, 293301.
  • 106
    Kovvali GK, Mehta B, Epstein CB & Lutzker SG (2001) Identification of partial loss of function p53 gene mutations utilizing a yeast-based functional assay. Nucleic Acids Res 29, E28.
  • 107
    Robert V, Michel P, Flaman JM, Chiron A, Martin C, Charbonnier F, Paillot B & Frebourg T (2000) High frequency in esophageal cancers of p53 alterations inactivating the regulation of genes involved in cell cycle and apoptosis. Carcinogenesis 21, 563565.
  • 108
    Di Como CJ & Prives C (1998) Human tumor-derived p53 proteins exhibit binding site selectivity and temperature sensitivity for transactivation in a yeast-based assay. Oncogene 16, 25272539.
  • 109
    Kato S, Han SY, Liu W, Otsuka K, Shibata H, Kanamaru R & Ishioka C (2003) Understanding the function–structure and function–mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis. Proc Natl Acad Sci USA 100, 84248429.
  • 110
    Baroni TE, Wang T, Qian H, Dearth LR, Truong LN, Zeng J, Denes AE, Chen SW & Brachmann RK (2004) A global suppressor motif for p53 cancer mutants. Proc Natl Acad Sci USA 101, 49304935.
  • 111
    Andreotti V, Ciribilli Y, Monti P, Bisio A, Lion M, Jordan J, Fronza G, Menichini P, Resnick MA & Inga A (2011) p53 Transactivation and the impact of mutations, cofactors and small molecules using a simplified yeast-based screening system. PLoS ONE 6, e20643.
  • 112
    Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, Kinzler KW & Vogelstein B (1993) Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature, 362, 857860.
  • 113
    Di Ventura B, Funaya C, Antony C, Knop M & Serrano L (2008) Reconstitution of Mdm2-dependent post-translational modifications of p53 in yeast. PLoS ONE 3, e1507.
  • 114
    Nigro JM, Sikorski R, Reed SI & Vogelstein B (1992) Human p53 and CDC2Hs genes combine to inhibit the proliferation of Saccharomyces cerevisiae. Mol Cell Biol 12, 13571365.
  • 115
    Bureik M, Jungbluth A, Drescher R & Wagner P (1997) Human p53 restores DNA synthesis control in fission yeast. Biol Chem 378, 13611371.
  • 116
    Mokdad-Gargouri R, Belhadj K & Gargouri A (2001) Translational control of human p53 expression in yeast mediated by 5′-UTR-ORF structural interaction. Nucleic Acids Res 29, 12221227.
  • 117
    St Clair S, Giono L, Varmeh-Ziaie S, Resnick-Silverman L, Liu W-J, Padi A, Dastidar J, DaCosta A, Mattia M & Manfredi JJ (2004) DNA damage-induced downregulation of Cdc25C is mediated by p53 via two independent mechanisms: one involves direct binding to the cdc25C promoter. Mol Cell 16, 725736.
  • 118
    Hadj Amor IY, Smaoui K, Chaabene I, Mabrouk I, Djemal L, Elleuch H, Allouche M, Mokdad-Gargouri R & Gargouri A (2008) Human p53 induces cell death and downregulates thioredoxin expression in Saccharomyces cerevisiae. FEMS Yeast Res 8, 12541262.
  • 119
    Haupt Y, Rowan S, Shaulian E, Vousden KH & Oren M (1995) Induction of apoptosis in Hela-cells by trans-activation-deficient p53. Genes Dev 9, 21702183.
  • 120
    Speidel D (2010) Transcription-independent p53 apoptosis: an alternative route to death. Trends Cell Biol 20, 1424.
  • 121
    Buttner S, Ruli D, Vogtle FN, Galluzzi L, Moitzi B, Eisenberg T, Kepp O, Habernig L, Carmona-Gutierrez D, Rockenfeller P et al. (2011) A yeast BH3-only protein mediates the mitochondrial pathway of apoptosis. EMBO J 30, 27792792.
  • 122
    Flaman JM, Frebourg T, Moreau V, Charbonnier F, Martin C, Chappuis P, Sappino AP, Limacher IM, Bron L, Benhattar J et al. (1995) A simple p53 functional assay for screening cell lines, blood, and tumors. Proc Natl Acad Sci USA 92, 39633967.
  • 123
    Balmelli-Gallacchi P, Schoumacher F, Liu JW, Eppenberger U, Mueller H & Picard D (1999) A yeast-based bioassay for the determination of functional and non-functional estrogen receptors. Nucleic Acids Res 27, 18751881.